Julie Harper, MD, discusses phase 3 data for Denifanstat, an oral FASN inhibitor, for acne.
Julie Harper, MD
Advertisement
Articles by Julie Harper, MD
She shares her top 5 considerations for all dermatology drug prescribers.
Advertisement
Latest Updated Articles
Julie Harper, MD, to Present a Rosacea Research Roundup and PearlsSeptember 27th 2023
Advertisement
Advertisement
Trending on Dermatology Times
1
Social Media Mythbusters: The Summer Skin Care "Shutdown"
2
Zasocitinib Shows High Skin Clearance at Hard-to-Treat Psoriasis Sites
3
Breakout Bulletin: July 13-July 17
4
New York Extends Nurse Practitioner Independent Practice Authority Through 2030
5